Advertisement
Loading...

argenx SE

ARGXNASDAQ
Healthcare
Biotechnology
$822.13
$19.43(2.42%)
U.S. Market is Open • 09:44

argenx SE (ARGX) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap50.9B
P/E Ratio21.69
EPS (TTM)$22.48
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$695.48
3 Months$774.20
1 Year Target$821.95

ARGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $821.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.69 and a market capitalization of 50.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.42%
5-Day Change
4.45%
1-Month Change
-0.75%
3-Month Change
0.02%
6-Month Change
-9.46%
Year-to-Date (YTD) Change
-2.24%
1-Year Change
54.46%
3-Year Change
102.43%
5-Year Change
201.92%
All-Time (Max) Change
3474.48%

Contact Information

31 10 703 8441
Laarderhoogtweg 25, Amsterdam, NaN, 1101EB

Company Facts

1,599 Employees
IPO DateMay 18, 2017
CountryNL
Actively Trading

Frequently Asked Questions